Compass Wealth Management’s Pfizer PFE Stock Holding History

Compass Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,956	Closed	-$126K	–	336
2025 Q1	$126K	Hold	4,956	–	–	0.03%	176
2024 Q4	$131K	Sell	4,956 -4,522	-48%	-$123K	0.03%	175
2024 Q3	$274K	Buy	9,478 +322	+4%	+$9.39K	0.06%	142
2024 Q2	$256K	Buy	9,156 +1,500	+20%	+$41.3K	0.06%	143
2024 Q1	$212K	Buy	7,656 +2,550	+50%	+$70.8K	0.05%	153
2023 Q4	$147K	Sell	5,106 -2,417	-32%	-$73.1K	0.04%	167
2023 Q3	$250K	Buy	7,523 +5,200	+224%	+$184K	0.08%	141
2023 Q2	$85.2K	Hold	2,323	–	–	0.03%	197
2023 Q1	$94.8K	Sell	2,323 -10	-0.4%	-$432	0.03%	190
2022 Q4	$120K	Buy	+2,333	New	+$112K	0.04%	177

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Compass Wealth Management's PFE Position: Q2 2025 in Review

Compass Wealth Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 4,956 shares — an estimated $126K sold.

Compass Wealth Management first reported a position in PFE in Q4 2022 and held it in 10 quarters. The position peaked at $274K in Q3 2024. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Compass Wealth Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Compass Wealth Management sold 4,956 Pfizer shares in Q2 2025, an estimated $126K.
Compass Wealth Management first reported a position in Pfizer in Q4 2022 and held it in 10 quarters.
Compass Wealth Management's Pfizer position peaked at $274K in Q3 2024.
2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Compass Wealth Management's 13F filing for Q2 2025, filed 8 Aug 2025.